IsoRay Inc (ISR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:IsoRay Inc (ISR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5332
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a radioactive isotope used in brachytherapy for the treatment of prostate, brain, lung, head, neck and gynecological cancers. Brachytherapy involves placing the radiation sources – seeds – very close to the tumor site in order to destroy the cancer cells. Cesium 131 provides a specifically targeted, quick-acting radiation treatment. Its initial application is the treatment of localized prostate cancer. It serves medical centers, hospitals and clinics across the US. IsoRay is headquartered in Richland, Washington, the US.

IsoRay Inc (ISR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IsoRay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IsoRay Inc, Medical Devices Deals, 2012 to YTD 2018 9
IsoRay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IsoRay Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
IsoRay to Raise USD8.3 Million in Private Placement of Shares 11
IsoRay Completes Private Placement Of Shares For US$14.7 Million 13
IsoRay Raises USD3.38 Million Private Placement Of Shares 14
IsoRay Amends Terms Of Public Offering Of Units For US$3.7 Million 15
IsoRay Inc – Key Competitors 16
IsoRay Inc – Key Employees 17
IsoRay Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
May 03, 2018: IsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter Increase 19
Apr 18, 2018: IsoRay Announces Preliminary Third Quarter Fiscal 2018 Financial Results 20
Jan 24, 2018: IsoRay Announces Preliminary Second Quarter F2018 Revenue of $1.54 Million, 50% Year-over-Year Increase 21
Nov 14, 2017: IsoRay Announces First Quarter Fiscal 2018 Financial Results 22
Aug 04, 2017: IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of $1.37 Million, 22% Year-over-Year Increase 23
May 10, 2017: IsoRay Announces Third Quarter Fiscal 2017 Financial Results 24
Feb 08, 2017: IsoRay Announces Second Quarter Fiscal 2017 Financial Results 26
Corporate Communications 28
Jun 19, 2018: IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO 28
Jun 05, 2018: IsoRay Announces Senior Management Change 29
Legal and Regulatory 30
Mar 09, 2017: IsoRay Announces Final Court Approval of Class Action Settlement 30
Product News 31
May 01, 2018: Sharpening the focus on focal therapy for prostate cancer treatment 31
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
IsoRay Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IsoRay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IsoRay Inc, Deals By Therapy Area, 2012 to YTD 2018 8
IsoRay Inc, Medical Devices Deals, 2012 to YTD 2018 9
IsoRay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IsoRay to Raise USD8.3 Million in Private Placement of Shares 11
IsoRay Completes Private Placement Of Shares For US$14.7 Million 13
IsoRay Raises USD3.38 Million Private Placement Of Shares 14
IsoRay Amends Terms Of Public Offering Of Units For US$3.7 Million 15
IsoRay Inc, Key Competitors 16
IsoRay Inc, Key Employees 17
IsoRay Inc, Subsidiaries 18

List of Figures
IsoRay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IsoRay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IsoRay Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[IsoRay Inc (ISR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mission Pharmacal Company:企業の戦略的SWOT分析
    Mission Pharmacal Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hang Lung Properties Limited:企業の戦略・SWOT・財務情報
    Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report Summary Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mochida Pharmaceutical Co Ltd (4534):企業の財務・戦略的SWOT分析
    Mochida Pharmaceutical Co Ltd (4534) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析
    R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Twenty-First Century Fox, Inc.:企業の戦略・SWOT・財務情報
    Twenty-First Century Fox, Inc. - Strategy, SWOT and Corporate Finance Report Summary Twenty-First Century Fox, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Defense Commissary Agency:企業の戦略的SWOT分析
    Defense Commissary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Bengal Energy Ltd (BNG):企業の財務・戦略的SWOT分析
    Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets in Australia’s Cooper Basin and India’s Cauvery Basin. The company holds interest in Toooko …
  • Grupo Herdez SA de CV:企業の戦略・SWOT・財務情報
    Grupo Herdez SA de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Herdez SA de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Prologic Limited:企業の戦略・SWOT・財務情報
    Prologic Limited - Strategy, SWOT and Corporate Finance Report Summary Prologic Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bechtel Power Corporation:企業の戦略的SWOT分析
    Bechtel Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Meridiana fly SpA:企業の戦略・SWOT・財務情報
    Meridiana fly SpA - Strategy, SWOT and Corporate Finance Report Summary Meridiana fly SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Forward Industries, Inc. (FORD):企業の財務・戦略的SWOT分析
    Forward Industries, Inc. (FORD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • First Solar Inc (FSLR):企業の財務・戦略的SWOT分析
    First Solar Inc (FSLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Kepler Weber S.A. (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber S.A. (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kunlun Energy Co Ltd (135):企業の財務・戦略的SWOT分析
    Kunlun Energy Co Ltd (135) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Goodrich Petroleum Corp (GDP):石油・ガス:M&Aディール及び事業提携情報
    Summary Goodrich Petroleum Corp (Goodrich) is an independent oil and gas company. It explores, develops and produces oil and natural gas from properties that include Tuscaloosa Marine Shale in Eastern Louisiana and Southwestern Mississippi, Haynesville Shale trend in north Louisiana and east Texas, …
  • Firstsource Solutions Ltd (FSL):企業の財務・戦略的SWOT分析
    Firstsource Solutions Ltd (FSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Reliance Worldwide Corporation Ltd (RWC):企業の財務・戦略的SWOT分析
    Reliance Worldwide Corporation Ltd (RWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Vaxart Inc (AVIR):企業の財務・戦略的SWOT分析
    Vaxart Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kurabo Industries Ltd (3106):企業の財務・戦略的SWOT分析
    Kurabo Industries Ltd (3106) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆